Acquiring Company
LumiThera
Acquired Company
DIOPSYS INC
PoulsboPine BrookInformation TechnologyHealthcareHealth CareHardwareContent And PublishingMedia And EntertainmentVideoCommerce And ShoppingConsumer ElectronicsDescription
LumiThera Inc., a commercial stage medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the completion of its acquisition of Diopsys, Inc., a leader in modern visual electrophysiology medical devices that help eye care professionals analyze the entire visual pathway for visual and neuro-visual disorders. Diopsys is now a wholly owned subsidiary of LumiThera.
Quick answer
LumiThera is acquiring DIOPSYS INC, announced March 3, 2022. LumiThera is based in Poulsbo, Washington, United States.
- How much did LumiThera pay for DIOPSYS INC?
- The deal value was not disclosed.
- What does LumiThera do?
- LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration.
- Where are LumiThera and DIOPSYS INC based?
- LumiThera is based in Poulsbo, Washington, United States. DIOPSYS INC is based in Pine Brook, New Jersey, United States.
- Who are the decision-makers at LumiThera?
- Fundz holds 3 contacts at LumiThera. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Hardware
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Waters Acquires Charge Detection Mass Spectrometry Technology To Broaden Its Application In Cell And Gene Therapy (February 1, 2022)
- Mntn Acquires Quickframe On Heels Of Ryan Reynolds’ Maximum Effort Deal (January 20, 2022)
- With $200M+ Investment Led By Psg, Backlight Announces Company Launch And Five Media Tech Acquisitions, $200M (April 12, 2022)
- R1 Rcm Announces Filing Of Registration Statement On Form S-4 Related To Proposed Acquisition Of Cloudmed (April 7, 2022)
- Lumanity Acquires Innovative Edge (March 30, 2022)
- Impact.Com Acquires Pressboard, Providing Publishers With A Best-In-Class Platform For Branded Content As Digital Advertising Is Deprioritized (March 15, 2022)
Who to call at LumiThera, and when
When LumiThera changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day LumiThera raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LumiThera, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LumiThera. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LumiThera makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired DIOPSYS INC?
DIOPSYS INC was acquired by LumiThera, based in Poulsbo. The deal was reported on March 3, 2022. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. LumiThera is privately held and operates in Information Technology.
When did LumiThera acquire DIOPSYS INC?
LumiThera's acquisition of DIOPSYS INC was reported on March 3, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does DIOPSYS INC do?
Diopsys, Inc. is a leader in modern visual electrophysiology medical devices that help eye care professionals analyze the entire visual pathway for visual and neuro-visual disorders. It is privately held, operating in Hardware, and is based in Pine Brook.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.